European Archives - Page 386 of 1589 - European Medical Journal

How to Tackle Exercise Barriers in Inflammatory Myopathies?

People with idiopathic inflammatory myopathies (IIM) face unique physical and emotional challenges when it comes to exercise.

5 minutes with Dr Henar Hevia, J&J Innovative Medicine

Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology, reveals what it’s like to work in oncology today, especially at J&J.

Breaking Barriers in Cervical Cancer Screening for LGBTQ+ AFAB Individuals

New research highlights how outdated cervical cancer screening guidelines in the U.S. fail to meet the needs of sexual and gender minoritized (SGM) people assigned female at birth.

AstraZeneca and Viseven win 2025 HBA ACE Awards

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of healthcare.

Labelling Shown to Affect Views on Early Blood Conditions

A new study finds that the way early blood conditions like clonal cytopenia of undetermined significance (CCUS) are labelled significantly affects how people perceive the disease and what treatments they prefer.

Study Uncovers Biomarkers That Could Guide Chronic Kidney Disease Care

A large UK study has shown that novel biomarkers reflecting kidney damage, fibrosis, inflammation, and cardiovascular disease can predict kidney failure and all-cause mortality in chronic kidney disease (CKD) with accuracy similar to established clinical risk factors.

SuperAging Study: Some Over Eighties Defy Cognitive Ageing and Memory Decline

SuperAgers defy expectations, retaining youthful memory and brain structure well into their eighties and beyond.

Apremilast Shows Long-Term Effectiveness in Treating Paediatric Psoriasis

Apremilast shows sustained 52-week efficacy and safety in children with moderate to severe plaque psoriasis.

Two US flags

AbbVie invests $195m in US expansion ahead of tariffs

AbbVie to invest $195m in manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug import tariffs.

Quadricuspid Aortic Valve Has Higher Heart Failure Risk Than Bicuspid Valve

Discover how quadricuspid aortic valve impacts heart failure risk and survival compared with bicuspid valve. Find out more.